HIV News and Research

RSS

HIV: New therapeutic approach to restore the effectiveness of immune cells

Prompted by the need to improve conventional treatments for people infected with the human immunodeficiency virus (HIV-1), a team from the Institut national de la recherche scientifique has identified a therapeutic approach to restore the effectiveness of immune cells.

8 Feb 2021

FDA continues to support the development of medical products to tackle new virus variants

As the public health agency responsible for regulating medical products, we must ensure that health care providers have the most up-to-date diagnostics, treatments and vaccines in their toolbox to fight this pandemic.

5 Feb 2021

Unmet treatment needs of female sex workers may contribute to HIV transmission in South Africa

The unmet HIV prevention and treatment needs of female sex workers and especially their male clients could contribute substantially to ongoing HIV transmission in South Africa, according to a new study led by researchers at the University of Bristol, UK.

5 Feb 2021

Study provides new insight about integrating treatment for HIV and opioid use disorder in Vietnam

An assessment published this week in the journal The Lancet HIV provides new insight about an initiative to integrate treatment of opioid use disorder along with HIV in Vietnam.

5 Feb 2021

SHREK proteins mediate broad spectrum antiviral host immunity, including against SARS-CoV-2

A new preprint posted to the bioRxiv server demonstrates that similar mucins and mucin-like proteins cannot only suppress HIV-1 infectivity via blockage of viral attachment to the host cells but can block infection by multiple enveloped viruses.

4 Feb 2021

Emory MVA COVID-19 vaccine proven safe and effective in mice and monkeys

Researchers at Yerkes National Primate Research Center, Emory University, have developed a COVID-19 vaccine that has proven safe and effective in mice and monkeys.

4 Feb 2021

Research could pave way for injectable gels that release drugs over time

Gels are formed by mixing polymers into fluids to create gooey substances useful for everything from holding hair in place to enabling contact lenses to float over the eye.

4 Feb 2021

Monoclonal antibodies against SARS-CoV-2 spike's N-terminal prove highly protective in vivo

A new study server reports highly protective neutralizing monoclonal antibodies against the SARS-CoV-2.

4 Feb 2021

Researchers develop prototype COVID-19 vaccine using DNA vaccine platform

It is necessary to develop additional COVID-19 vaccines, as different vaccine approaches have their advantages and disadvantages and may work synergistically.

4 Feb 2021

Study gives new clues to how muscle wasting occurs on a cellular level

Muscle wasting, or the loss of muscle tissue, is a common problem for people with cancer, but the precise mechanisms have long eluded doctors and scientists. Now, a new study led by Penn State researchers gives new clues to how muscle wasting happens on a cellular level.

3 Feb 2021

Phase 1 clinical trial of novel HIV vaccine approach shows promising results

A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, IAVI and Scripps Research announced today.

3 Feb 2021

Experimental intranasal influenza vaccine produces durable immune response

An experimental single-dose, intranasal influenza vaccine was safe and produced a durable immune response when tested in a Phase 1 study published in the Journal of Clinical Investigation.

3 Feb 2021

Long COVID-19 symptoms not associated with reduced cell-mediated immunity, finds study

A new preprint examines Long COVID-19, aiming to identify the underlying immunologic status in such patients.

3 Feb 2021

Researchers report trial results of rectal microbicides at HIV R4P Virtual Conference

Researchers seeking to develop on-demand and behaviorally congruent HIV prevention options for people who practice anal sex are reporting the results of three early phase clinical trials of rectal microbicides at this week's HIV Research for Prevention (HIV R4P) Virtual Conference.

3 Feb 2021

Fear-based messaging fails to reduce risky driving behaviour, indicates study

New drivers between the ages of 15 and 25 account for nearly half of the more than one million road deaths that occur worldwide each year, according to the World Health Organization. Educational programs often use fear-based messaging and films of crash scenes to reduce risky driving behavior among young people.

3 Feb 2021

HIV News and Research

HIV: New therapeutic approach to restore the effectiveness of immune cells

FDA continues to support the development of medical products to tackle new virus variants

Unmet treatment needs of female sex workers may contribute to HIV transmission in South Africa

Study provides new insight about integrating treatment for HIV and opioid use disorder in Vietnam

SHREK proteins mediate broad spectrum antiviral host immunity, including against SARS-CoV-2

Emory MVA COVID-19 vaccine proven safe and effective in mice and monkeys

Research could pave way for injectable gels that release drugs over time

Monoclonal antibodies against SARS-CoV-2 spike's N-terminal prove highly protective in vivo

Researchers develop prototype COVID-19 vaccine using DNA vaccine platform

Study gives new clues to how muscle wasting occurs on a cellular level

Phase 1 clinical trial of novel HIV vaccine approach shows promising results

Experimental intranasal influenza vaccine produces durable immune response

Long COVID-19 symptoms not associated with reduced cell-mediated immunity, finds study

Researchers report trial results of rectal microbicides at HIV R4P Virtual Conference

Fear-based messaging fails to reduce risky driving behaviour, indicates study

Johnson & Johnson SARS-CoV-2 vaccine shows promise in clinical trials

WHO recommends dapivirine vaginal ring as additional HIV prevention choice for at-risk women

Increased access to testing, treatment has reduced hepatitis C in low- and middle-income countries

When your chance for a covid shot comes, don’t worry about the numbers

Use of antiviral and antiretroviral medication could have detrimental impact on crops

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News